Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 14 July 2022
      Gap between EU vision and national competencies affects health agenda
 
 
Lars Fruergaard Jørgensen, CEO of Novo Nordisk and first vice-president of EFPIA
 
"It’s interesting to reflect that the industry brought five different vaccines in record time, all of those based on a certain degree of innovation (...). Next time around, we have to be lucky again that somebody else has invested in some science that is ready to be used. We also scaled up manufacturing in record time, so that billions of doses were basically available for the whole world. (...)

Still, there is a political agenda in the Western world to feel maybe some sort of bad conscience and they are proposing to waver IP rights in future situations. I get a bit emotional because I think this is politics at its worst, as it’s not helping anyone. It’s actually destroying the incentive to make the next version of vaccine or cure we all need."

Read more →
 
 
      News
 
  12 July 2022 EFPIA statement on the EU4Health 2023 work program

By funding strategic initiatives with clear EU added value, the EU4Health program can support Member States in transforming...

Read more →
 
 
 
      Blogs
 
  13 July 2022 Social consensus on extending screening programs and the right to be forgetten

A guest blog by Forum of International R&D Pharmaceutical Companies, Slovenia

Read more →
 
 
 
  12 July 2022 Leaving no stone unturned — Europe beating cancer, together

The EU’s ambitious goals to protect cancer patients could transform lives and save millions more. A properly-implemented...

Read more →
 
 
 
      Animal use and welfare in pharmaceutical R&D
The pharmaceutical industry is committed to responsible animal use, with tangible outcomes leading to improved animal welfare and high-quality science. Check our report for a list of over 70 examples of 3Rs (Replace, Reduce, Refine) in action. 

 
 
      What we are reading
Voice of EHDEN 11 July 2022  (Anchor, by Spotify) Read more →
Innovation or stagnation? EU pharma industry at a crossroads ahead of rules revision 08 July 2022  (Euractiv) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe